Overview

A Study to Evaluate the Effect of Oral Mirabegron on the Heart in Healthy Males and Females

Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the effect of repeat oral dosing of mirabegron on ECG (electrocardiogram) measurements.
Phase:
Phase 1
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Mirabegron
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination